SCOPUS 정보 검색 플랫폼

Thyroid

Volumn 20, Issue 9, 2010, Pages 1043-1044

Sorafenib-induced destructive thyroiditis

(5) Iavarone, Massimo a,b Perrino, Michela b,c Viganò, Mauro a,b Beck Peccoz, Paolo b,c Fugazzola, Laura b,c

a AM and A Migliavacca Center for Liver Disease (Italy)

b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO (Italy)

c UNIVERSITY OF MILAN (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR DIPIVOXIL; LAMIVUDINE; LIOTHYRONINE; PERTECHNETIC ACID TC 99M; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PREDNISONE; PROPANOL; PROTEIN RET; RAF PROTEIN; SORAFENIB; SUNITINIB; THYROGLOBULIN; THYROTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ADULT; CASE REPORT; DESTRUCTIVE THYROIDITIS; DIARRHEA; DYSPHONIA; ECHOGRAPHY; FATIGUE; FREE LIOTHYRONINE INDEX; HAND FOOT SYNDROME; HEPATITIS B; HUMAN; HYPERTENSION; KIDNEY CARCINOMA; LETTER; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; RASH; SIDE EFFECT; THYROGLOBULIN BLOOD LEVEL; THYROID DISEASE; THYROID FUNCTION; THYROID SCINTISCANNING; THYROIDITIS; THYROTROPIN BLOOD LEVEL; TREATMENT DURATION; TREATMENT RESPONSE; WEIGHT REDUCTION;

ANTINEOPLASTIC AGENTS; BENZENESULFONATES; CARCINOMA, HEPATOCELLULAR; CHRONIC DISEASE; HEPATITIS B, CHRONIC; HUMANS; IODINE RADIOISOTOPES; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREDNISONE; PROPRANOLOL; PROTEIN KINASE INHIBITORS; PYRIDINES; TECHNETIUM; THYROIDITIS;

EID: 77956530796 PISSN: 10507256 EISSN: None Source Type: Journal
DOI: 10.1089/thy.2010.0070 Document Type: Letter

Times cited : (13)

References (6)

1
- 33846148701
- Sorafenib in advanced clear-cell renal-cell carcinoma
- Target Study Group
- Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Siebels M, Negrier S, Chevreau C, Solska E, Desai AA, Rolland F, Demkow T, Hutson TE, Gore M, Freeman S, Schwartz B, Shan M, Simantov R, Bukowski RM; TARGET Study Group 2007 Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356:125-134.
- (2007) N. Engl. J. Med. , vol.356 , pp. 125-134
- Escudier, B.¹ Eisen, T.² Stadler, W.M.³ Szczylik, C.⁴ Oudard, S.⁵ Siebels, M.⁶ Negrier, S.⁷ Chevreau, C.⁸ Solska, E.⁹ Desai, A.A.¹⁰ Rolland, F.¹¹ Demkow, T.¹² Hutson, T.E.¹³ Gore, M.¹⁴ Freeman, S.¹⁵ Schwartz, B.¹⁶ Shan, M.¹⁷ Simantov, R.¹⁸ Bukowski, R.M.¹⁹

2
- 47949116252
- Sorafenib in advanced hepatocellular carcinoma
- SHARP Investigators Study Group
- Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Hä ussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J; SHARP Investigators Study Group 2008 Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378-390.
- (2008) N. Engl. J. Med. , vol.359 , pp. 378-390
- Llovet, J.M.¹ Ricci, S.² Mazzaferro, V.³ Hilgard, P.⁴ Gane, E.⁵ Blanc, J.F.⁶ De Oliveira, A.C.⁷ Santoro, A.⁸ Raoul, J.L.⁹ Forner, A.¹⁰ Schwartz, M.¹¹ Porta, C.¹² Zeuzem, S.¹³ Bolondi, L.¹⁴ Greten, T.F.¹⁵ Galle, P.R.¹⁶ Seitz, J.F.¹⁷ Borbath, I.¹⁸ Hä Ussinger, D.¹⁹ Giannaris, T.²⁰ more..

3
- 38849093794
- Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib
- Tamaskar I, Bukowski R, Elson P, Ioachimescu AG, Wood L, Dreicer R, Mekhail T, Garcia J, Rini BI 2008 Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib. Ann Oncol 19:265-268.
- (2008) Ann. Oncol. , vol.19 , pp. 265-268
- Tamaskar, I.¹ Bukowski, R.² Elson, P.³ Ioachimescu, A.G.⁴ Wood, L.⁵ Dreicer, R.⁶ Mekhail, T.⁷ Garcia, J.⁸ Rini, B.I.⁹

4
- 57749189578
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: A phase III randomised double-blind placebo-controlled trial
- Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS, Luo R, Feng J, Ye S, Yang TS, Xu J, Sun Y, Liang H, Liu J, Wang J, Tak WY, Pan H, Burock K, Zou J, Voliotis D, Guan Z 2009 Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 10:25-34.
- (2009) Lancet. Oncol. , vol.10 , pp. 25-34
- Cheng, A.L.¹ Kang, Y.K.² Chen, Z.³ Tsao, C.J.⁴ Qin, S.⁵ Kim, J.S.⁶ Luo, R.⁷ Feng, J.⁸ Ye, S.⁹ Yang, T.S.¹⁰ Xu, J.¹¹ Sun, Y.¹² Liang, H.¹³ Liu, J.¹⁴ Wang, J.¹⁵ Tak, W.Y.¹⁶ Pan, H.¹⁷ Burock, K.¹⁸ Zou, J.¹⁹ Voliotis, D.²⁰ Guan, Z.²¹ more..

5
- 34548764576
- A novel tyrosinekinase selective inhibitor sunitinib induces transient hypothyroidism by blocking iodine uptake
- Mannavola D, Coco P, Vannucchi G, Bertuelli R, Carletto M, Casali PG, Beck-Peccoz P, Fugazzola L 2007 A novel tyrosinekinase selective inhibitor, sunitinib, induces transient hypothyroidism by blocking iodine uptake. J Clin Endocrinol Metab 92:3531-3534.
- (2007) J. Clin. Endocrinol. Metab. , vol.92 , pp. 3531-3534
- Mannavola, D.¹ Coco, P.² Vannucchi, G.³ Bertuelli, R.⁴ Carletto, M.⁵ Casali, P.G.⁶ Beck-Peccoz, P.⁷ Fugazzola, L.⁸

6
- 51649122915
- Thyrotoxicosis during sunitinib treatment for renal cell carcinoma
- Grossmann M, Premaratne E, Desai J, Davis D 2008 Thyrotoxicosis during sunitinib treatment for renal cell carcinoma. Clin Endocrinol 69:669-672.
- (2008) Clin. Endocrinol. , vol.69 , pp. 669-672
- Grossmann, M.¹ Premaratne, E.² Desai, J.³ Davis, D.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.